Reactogenicity and Concomitant Administration of the COVID-19 Booster and Influenza Vaccine.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA network open"
DOI: 10.1001/jamanetworkopen.2022.22246
Abstract: Concomitant administration of the COVID-19 vaccine booster and the seasonal influenza vaccine could support uptake of both vaccines, augmenting protection against these preventable infectious diseases with potential implications for racial and ethnic disparities in vaccination… read more here.
Keywords: reactogenicity; influenza vaccine; covid; booster ... See more keywords
Geographic, Occupational, and Sociodemographic Variations in Uptake of COVID-19 Booster Doses Among Fully Vaccinated US Adults, December 1, 2021, to January 10, 2022
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.27680
Abstract: Key Points Question How has uptake of COVID-19 booster doses among fully vaccinated US adults varied by geographic location, occupation, and sociodemographic characteristics? Findings In this cross-sectional survey study of 135 821 US adults aged 18… read more here.
Keywords: fully vaccinated; doses among; booster doses; booster ... See more keywords
Infections, Hospitalizations, and Deaths Among US Nursing Home Residents With vs Without a SARS-CoV-2 Vaccine Booster
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.45417
Abstract: Key Points Question What is the estimated vaccine effectiveness up to 12 weeks for the first COVID-19 mRNA booster vaccines administered in US nursing homes? Findings In this cohort study of 10 949 residents of… read more here.
Keywords: infections hospitalizations; hospitalizations deaths; booster; among nursing ... See more keywords
COVID-19 Booster Vaccination Among Individuals With Schizophrenia in Israel.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA psychiatry"
DOI: 10.1001/jamapsychiatry.2022.0382
Abstract: Importance Individuals with schizophrenia are at higher risk for severe COVID-19 illness and mortality. Previous reports have demonstrated vaccination gaps among this high-risk population; however, it is unclear whether these gaps have continued to manifest… read more here.
Keywords: vaccination among; individuals schizophrenia; vaccination; among individuals ... See more keywords
Current evidence on efficacy of COVID‐19 booster dose vaccination against the Omicron variant: A systematic review
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.27697
Abstract: Coronavirus disease 2019 (COVID‐19) is an ongoing pandemic, which affected around 45 million confirmed cases of COVID‐19, including more than 6 million deaths. However, on November 24, 2021, the World Health Organization announced a new… read more here.
Keywords: omicron variant; booster dose; covid; booster ... See more keywords
T‐cell responses to SARS‐CoV‐2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.27814
Abstract: The rapidly spreading severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Omicron variant contains more than 30 mutations that mediate escape from antibody responses elicited by prior infection or current vaccines. Fortunately, T‐cell responses are highly… read more here.
Keywords: omicron spike; cell responses; booster; cov omicron ... See more keywords
Ad5‐nCoV booster and Omicron variant breakthrough infection following two doses of inactivated vaccine elicit comparable antibody levels against Omicron variants
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28163
Abstract: Little information is available for antibody levels against SARS‐CoV‐2 variants of concern induced by Omicron breakthrough infection and a third booster with an inactivated vaccine (InV) or Ad5‐nCoV in people with completion of two InV… read more here.
Keywords: omicron; rbd igg; ad5 ncov; booster ... See more keywords
Long‐term variations and potency of neutralizing antibodies against Omicron subvariants after CoronaVac‐inactivated booster: A 7‐month follow‐up study
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28279
Abstract: The long‐term protective efficacy of neutralizing antibodies (Nabs) against Omicron subvariants after inactivated booster vaccines remains elusive. During the follow‐up study, 54 healthy volunteers aged 20–31 years received inactivated CoronaVac booster vaccinations and were monitored… read more here.
Keywords: long term; omicron subvariants; booster; neutralizing antibodies ... See more keywords
Delay in booster schedule as a control parameter in vaccination dynamics
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Mathematical Biology"
DOI: 10.1007/s00285-019-01424-6
Abstract: The use of multiple vaccine doses has proven to be essential in providing high levels of protection against a number of vaccine-preventable diseases at the individual level. However, the effectiveness of vaccination at the population… read more here.
Keywords: vaccination; control parameter; booster; booster schedule ... See more keywords
Determining the Optimal Vaccination Schedule for Herpes Zoster: a Cost-Effectiveness Analysis
Sign Up to like & getrecommendations! Published in 2017 at "Journal of General Internal Medicine"
DOI: 10.1007/s11606-016-3844-6
Abstract: ABSTRACTBACKGROUNDThe Advisory Committee on Immunization Practices recommends a single dose of herpes zoster (HZ) vaccine in persons aged 60 years or older, but the efficacy decreases to zero after approximately 10 years. A booster dose administered after… read more here.
Keywords: booster; analysis; cost effectiveness; vaccination ... See more keywords
Response to tozinameran (BNT162b2) booster in twice-vaccinated kidney transplant and maintenance dialysis patients
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Nephrology"
DOI: 10.1007/s40620-021-01235-3
Abstract: On 22-Sep-2021 the U.S. Food and Drug Administration amended the emergency use authorization for the PfizerBioNTech COVID-19 Vaccine (tozinameran) to allow the use of a single booster dose, to be administered at least 6 months… read more here.
Keywords: dialysis patients; dialysis; maintenance dialysis; booster ... See more keywords